GILTERITINIB for Product used for unknown indication: Side Effects & Safety Data
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
There are 511 adverse event reports in the FDA FAERS database where GILTERITINIB was used for Product used for unknown indication.
Most Reported Side Effects for GILTERITINIB
| Side Effect | Reports | % | Deaths | Hosp. |
|---|---|---|---|---|
| Acute myeloid leukaemia | 366 | 10.0% | 247 | 120 |
| Febrile neutropenia | 346 | 9.4% | 115 | 235 |
| Off label use | 334 | 9.1% | 79 | 104 |
| Platelet count decreased | 327 | 8.9% | 61 | 139 |
| Pneumonia | 302 | 8.2% | 133 | 192 |
| Myelosuppression | 300 | 8.2% | 75 | 114 |
| Pyrexia | 281 | 7.7% | 84 | 193 |
| Death | 206 | 5.6% | 206 | 52 |
| Product use issue | 189 | 5.2% | 55 | 50 |
| Hepatic function abnormal | 181 | 4.9% | 61 | 93 |
| Neutrophil count decreased | 162 | 4.4% | 35 | 60 |
| Acute myeloid leukaemia recurrent | 155 | 4.2% | 39 | 44 |
| Anaemia | 154 | 4.2% | 37 | 75 |
| Infection | 153 | 4.2% | 76 | 89 |
| Cytopenia | 152 | 4.1% | 32 | 36 |
Other Indications for GILTERITINIB
Acute myeloid leukaemia (1,963)
Acute myeloid leukaemia recurrent (669)
Acute myeloid leukaemia refractory (548)
Flt3 gene mutation (210)
Acute myeloid leukaemia (in remission) (21)
Acute monocytic leukaemia (20)
Acute leukaemia (19)
Leukaemia (17)
Acute myelomonocytic leukaemia (16)
Chronic myelomonocytic leukaemia (15)
Other Drugs Used for Product used for unknown indication
OXYCODONE (129,391)
ADAPALENE (91,681)
APIXABAN (88,417)
ETANERCEPT (71,866)
SACUBITRIL\VALSARTAN (69,693)
ACETAMINOPHEN (68,427)
AVOBENZONE\OCTISALATE\OCTOCRYLENE (65,206)
ADALIMUMAB (63,549)
EVOLOCUMAB (60,696)
MORPHINE (59,440)